Doxorubicin (A) followed by docetaxel (T) versus doxorubicin plus docetaxel (AT) in the adjuvant treatment of breast cancer (BC)

被引：2
|
作者：
Di Leo, A
Crown, J
Nogaret, LM
Duffy, K
Bartholomeus, S
Dolci, S
Rowan, S
O'Higgins, N
Riva, A
Piccart, MJ
机构：
[1] Inst Jules Bordet, B-1000 Brussels, Belgium
[2] St Vincents Hosp, Dublin 4, Ireland
[3] Rhone Poulenc Rorer, Paris, France
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(98)80153-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
166
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: Results of a feasibility study
    Cardoso, F
    Ferreira, AF
    Crown, J
    Dolci, S
    Paesmans, M
    Riva, A
    Di Leo, A
    Piccart, MJ
    [J]. ANTICANCER RESEARCH, 2001, 21 (1B) : 789 - 795
  • [2] A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
    Schneeweiss, A.
    Marme, F.
    Ruiz, A.
    Manikhas, A. G.
    Bottini, A.
    Wolf, M.
    Sinn, H. -P.
    Mansouri, K.
    Kennedy, L.
    Bauknecht, T.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (03) : 609 - 617
  • [3] Use of Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy for Breast Cancer
    Livi, L.
    Meattini, I.
    Cardillo, C. De Luca
    Scotti, V.
    Agresti, B.
    Franzese, C.
    Sanchez, L.
    Nori, J.
    Bertocci, S.
    Cassani, S.
    Bianchi, S.
    Cataliotti, L.
    Biti, G.
    [J]. JOURNAL OF CHEMOTHERAPY, 2011, 23 (01) : 36 - 39
  • [4] Results of clinical endpoints of a randomized phase It trial with doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as primary systemic therapy for early breast cancer
    Schneeweiss, A.
    Ruiz, A.
    Rovira, P.
    Bottini, A.
    Manikhas, A.
    Wacker, J.
    Schumacher, T.
    Wolf, M.
    Segui, M.
    Sinn, P.
    Kennedy, L.
    Mansouri, K.
    Bauknecht, T.
    [J]. BREAST, 2009, 18 : S63 - S63
  • [5] Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer:: A randomized phase II trial
    Schneeweiss, Andreas
    Lauschner, Ilka
    Ruiz, Amparo
    Guerrero, Angel
    Sanchez-Rovira, Pedro
    Segui, Miguel Angel
    Goerke, Kay
    Wolf, Michael
    Manikhas, Alexey G.
    Wacker, Juergen
    Marme, Frederik
    Lichter, Peter
    Sinn, Hans-Peter
    Sohn, Christof
    Mansouri, Kambiz
    Bauknecht, Thomas
    Hahn, Meinhard
    [J]. CLINICAL BREAST CANCER, 2007, 7 (07) : 555 - 558
  • [6] COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER
    Jones, S.
    Chen, L.
    Tangirala, M.
    Asmar, L.
    Airia, P.
    Thompson, M. F.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A45 - A45
  • [7] Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer
    Gradishar, WJ
    Wedam, SB
    Jahanzeb, M
    Erban, J
    Limentani, SA
    Tsai, KT
    Olsen, SR
    Swain, SM
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (08) : 1297 - 1304
  • [8] Sequential doxorubicin plus vinorelbine (AV) followed by docetaxel plus carboplatin (DC) as neoadjuvant chemotherapy for advanced breast cancer (BC)
    Santisteban, Marta
    De la Cruz, Susana
    Sola, Jesus Javier
    Aramendia, Jose Manuel
    Espinos, Jaime
    Garran, Cristina
    Martinez-Regueira, Fernando
    Zornoza, Gerardo
    Fernandez-Hidalgo, Oscar
    Nieto, Yago
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 86 - 86
  • [9] Biweekly administration of doxorubicin plus docetaxel (AT) as neoadjuvant treatment of stage IIB and III breast cancer (BC)
    Garcia, MJ
    Calvo, L
    Mel, JR
    Garcia, PA
    Ramos, M
    Antolin, S
    Vazquez, S
    Rodriguez, R
    Rodriguez, A
    Anton, LM
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S58 - S58
  • [10] Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
    Gwak, Geumhee
    Kim, Ji-Young
    Park, Keongmee
    Shin, Young Joo
    Cho, Hyunjin
    Park, Sung Jin
    Yang, Geun Ho
    Bae, Byung Noe
    Kim, Ki Whan
    Han, Sehwan
    [J]. JOURNAL OF BREAST CANCER, 2011, 14 (02) : 129 - 134
12345